New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.The companies, namely Sun Pharma, Zydus Lifesciences, and Dr. Reddy’s Laboratories, launched their variants a day after Hyderabad-based Natco Pharma launched its generic semaglutide injection in India, priced at Rs 1,290 per month.Sun Pharma launched semaglutide…
Trending
- Brown (2026) Review: Karisma Kapoor Delivers a Career-Defining Performance in This Hauntingly Beautiful Zee5 Crime Drama
- Gullak Season 5 Review: The Mishras Are Back and More Heartwarming Than Ever
- Mango Pachcha Review (2026): A Gritty Crime Drama That Hits Close to Home
- Peddi (2026) Movie Review: Ram Charan’s Career-Best Performance Powers a Stirring Tale of Grit, Identity and Belonging
- Parimala And Co (2026) Review: Pandiraj’s Warm Whodunit Is a Comfortable, Crowd-Pleasing Ride
- Bandar (2026) Review: Bobby Deol’s Most Daring Performance Yet in Anurag Kashyap’s Brutal Prison Drama
- Hai Jawani Toh Ishq Hona Hai Review: Varun Dhawan’s Most Entertaining Comedy in Years
- Maa Behen Review (2026): Madhuri Dixit, Triptii Dimri Deliver a Wickedly Funny Crime-Comedy That Refuses to Apologise